Alentis Therapeutics
Latest round
- Series D
Last raised
- Nov 2024
Total raised
- $360M
Investors
- 16
About Alentis Therapeutics
Alentis Therapeutics AG specializes in targeted therapies for cancer and fibrosis. Founded in 2019 and headquartered in Allschwil, Switzerland, the company has undergone strategic pivots to refine its focus on innovative treatments.Alentis Therapeutics specializes in developing innovative treatments targeting cancer and fibrosis through its core product offerings of anti-Claudin-1 antibody-drug conjugates (ADCs) and monoclonal antibodies.P02, designed for squamous cancers, and the monoclonal antibody lixudebart, aimed at organ fibrosis. These products function by specifically targeting Claudin-1, which plays a pivotal role in tumor cell signaling and the rigidity of the extracellular matrix, thereby promoting the selective killing of cancer cells and reversing fibrotic conditions.Alentis Therapeutics generates revenue through strategic partnerships and clinical collaborations aimed at advancing their therapeutic pipeline.P02 and lixudebart.Alentis Therapeutics AG is focused on advancing its clinical pipeline with new products aimed at addressing significant medical needs in oncology and fibrosis. The company plans to expand its market presence in North America and Europe by 2025.
Who invested in Alentis Therapeutics
16 investors across 4 rounds
See all investors in Alentis Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alentis Therapeutics
Who invested in Alentis Therapeutics?
Alentis Therapeutics has 16 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alentis Therapeutics raised?
Alentis Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Alentis Therapeutics last raise money?
Alentis Therapeutics's most recent round on record is a Series D, in Nov 2024.
What does Alentis Therapeutics do?
Alentis Therapeutics AG specializes in targeted therapies for cancer and fibrosis.
Where is Alentis Therapeutics headquartered?
Alentis Therapeutics is headquartered in Allschwil, Switzerland.
Which VCs invest in companies like Alentis Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Alentis Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Alentis Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.